Different DNA Binding and Damage Mode between Anticancer Antibiotics Trioxacarcin A and LL-D49194α1

Area of Science:

• Molecular Biology
• Drug Discovery
• Structural Biology

Background:

• Trioxacarcin A (TXN) is a potent cytotoxic antibiotic.
• LL-D49194α1 (LLD) is a TXN analogue with a distinct glycosylation pattern, previously in clinical trials.
• The DNA binding mechanism of LLD remains unclear.

Purpose of the Study:

• To elucidate the high-resolution solution structures of dsDNA bound to TXN and LLD.
• To compare the DNA binding and damaging effects of TXN and LLD.
• To understand the biological consequences of differing DNA interactions.

Main Methods:

• High-resolution solution structure determination of fluorinated dsDNA and its complexes with TXN and LLD.
• Biochemical assays to assess DNA stability and damage.
• Comparative analysis of TXN- and LLD-alkylated dsDNA.

Main Results:

• The study determined the structures of dsDNA covalently bound to TXN and LLD.
• TXN-alkylated dsDNA maintained helix conformation.
• LLD-alkylated dsDNA showed reduced stability and increased denaturation compared to TXN-alkylated dsDNA.
• LLD induced greater DNA damage despite lower in vitro cytotoxicity.

Conclusions:

• Differences in sugar substitutions between TXN and LLD significantly alter their DNA binding and damaging properties.
• LLD's distinct interaction with dsDNA leads to greater DNA instability and denaturation, resulting in unique biological effects.
• This research provides insights into the structure-activity relationships of TXN analogues for potential therapeutic development.